Subscribe for Updates

Exceptional Experience

We have gathered a team of specialists to achieve an ambitious plan of growing the company and strengthening the brand recognition to match the incredible potential of the flourishing demand.

We are a fully integrated European based medical cannabis company. Our strategic investments and partnerships will allow us to control every stage of the production path - from research, cultivation and processing to distribution. To focus on each integrated CBD stage, we’ve organized the corporate structure as of follows:

FARZAD Moshfeghi

BSC, MPHIL
Winchester Corporate,
CO-Founder

Farzad is a Physics graduate from the University of Manchester Institute of Science and Technology. He has 30 years experience working for large organizations such as JPMorgan, Goldman Sachs, Merrill Lynch, Credit Suisse and Barclays Capital specializing in derivatives pricing, risk management and regulatory reporting.

He spent 2.5 years at Otsuka pharmaceuticals Europe - A Japanese company focused on mental health advising them in Transparency, Compliance and regulatory reporting. Farzad is also a founder of Finity Asset, specializing in advising junior mining and oil & gas companies raise funding. Farzad has been responsible for the commercial development of Winchester MD (Formerly Green Biosciences).

MARTI Moshfeghi

Winchester Wellness,
CO-Founder

Graduated with a major in Economics from McGill University (Montreal) Marti has over 2 years direct experience working in the UK Cannabis industry. Marti is the principal founder of Winchester MD (formerly Green Biosciences) and has been responsible for the successful growth of the brand HempElf – UK’s fastest growing CBD company. Marti has implemented streamlined operational controls that have kept costs at HempElf low while expanding the UK customer base from zero to 15,000 in just 12 months. He is now applying the same principles to grow HempElf in the rest of Europe.

Dan Kriznic

CPA/CA
Public Market & Business Development
CO-Founder

Dan Kriznic has founded and co-founded a number of successful private and public companies in emerging markets with more recent involvement in Cannabis in Canada, US, Jamaica, Peru and Europe.Collectively he has been responsible for 9 public listings, $243 million in M&A transactions, $175 million in financings and $281 million in value for shareholders from selling companies. Dan founded High Standard after recognizing a need for financial and advisory services in fast growing emerging sectors.

He is the former CEO, Chairman and founder of Invictus MD Strategies (TSXV: GENE; OTC: IVITF) where he spearheaded over $62 million in acquisitions and raised over $115 million in financings. Dan now serves as advisor to the CEO and Chairman.

Dan co-founded Lithium X in 2015, as CFO and later as advisor to the chairman. Lithium X, a lithium exploration company, recently sold for $265 million in December 2017, representing a return to shareholders of 1,443%. He has been responsible for incubating companies in a variety of industries, including Cannabis, Technology, Education, Real Estate, Lithium and Healthcare. Through his strategic direction and execution, these companies have grown from nominal to over $1 billion in enterprise value. Dan began his career with 10 years at Deloitte, where he served in leadership roles in its Assurance and Advisory group, advising public and privately held companies. He is a Chartered Professional Accountant.

Ewan Phillips FCA

CHIEF FINANCIAL OFFICER

Ewan started his career at Deloitte focusing initially on audit and subsequently corporate finance. After leaving Deloitte he spent 17 years at Deltex Medical Group plc (LON:DEMG) – a health care company in the UK, where as CFO led the company to an IPO on the AIM gaining valuable exposure to raising capital, investor relations, corporate governance and scaling the business from 15 to over 100 employees and 20x sales growth. Ewan has completed over 50 finance transactions raising over £250 million and over 50 M&A transactions in aggregate excess value of £1 billion. He is a Chartered Accountant.

Fraser McGee

Legal Officer

Fraser McGee is a UK qualified solicitor and specialised in corporate finance and investment fund work with prominent City law firms before moving to work in in-house with investment banks. After working as general counsel at the globally focused hedge fund RAB Capital plc with the Special Situations, Energy and Technology Funds Fraser became the CEO of an AIM quoted natural resources business, partnering with the Majors before setting up an independent consultancy business to provide general counsel services to the alternative investment sector. That work extended to the European medical cannabis space from the early part of 2018 and included working with networks of entrepreneurs, professional service providers and investors in the industry around the world.

Fraser is also admitted as a solicitor of the Eastern Caribbean Supreme Court and has practised as an off-shore lawyer with a BVI and Cayman Islands law firm.

Natasha Collins

VP Finance

Natasha is a Chartered Professional Accountant with over 12 years of experience advising public and private companies in the areas of finance and accounting. She has experience with a variety of industries including blockchain technology, brand licensing, agriculture, franchising. As CFO of High Standard Capital Corp, Natasha is actively involved in assisting clients in obtaining a public listing, raising money, M&A transactions as well as ongoing regulatory compliance and financial reporting. Throughout her career, she has participated in M&A transactions with cumulative values in excess of $265MM and assisted with private placements in excess of $40MM.

Prior to joining High Standard, Natasha spent over six years in the assurance and advisory division at Deloitte, one of Canada’s leading professional services firms. In addition to this, Natasha has worked as the Director of Finance at Invictus MD Strategies Corp (TSXV: GENE –OTC: IVITF) and Senior Financial Manager at Mr. Lube Canada. Natasha holds a Bachelor’s degree in Accounting from British Columbia Institute of Technology and received her CPA designation in 2010.

Seann Einerssen

VP of Product & Brand Development

An award winning, multi-talented creative director with extensive experience in brand development, product advertising and design. He is a passionate and inventive creator of innovative marketing strategies and campaigns. Seann brings a fresh and unique style to his campaigns and has been acknowledged for this through multiple industry awards.

Cultivation Partnership

VivoGreenare a leading expert in high tech cultivation practices including hydroponics, fogponics, aeroponics and indoor GMP cultivation plants. Using advanced cultivation methods such as Out Soil, they have made it possible to achieve enormous quantitative and qualitative increases in production and increase cultivation density to achieve higher yields.

By optimizing the use of labour, fertilizer, water, waste and crop cycles Vivo Green has created processes that reduce energy consumption, avoid the use of pesticide and insectoids and pollution of groundwater while protecting from fungal and bacterial disease.

Vivo Green’s cultivation is absolutely organic.

Legal Counsel

International law firm Hill Dickinson are the leading medical cannabis law firm in the UK. The Corporate team has a strong ECM reputation and advised on the first medical cannabis investment by an AIM listed company in the UK (FastForward Innovations’ investment in Nuuvera Inc. in 2017) and in March 2018 advised Sativa Investments PLC on the first IPO of a medical cannabis company in the UK since GW Pharma in 2001.

Hill Dickinson currently advise a number of leading UK, European and North American companies, private equity groups and institutions on medical cannabis law and regulation as well as licensing and corporate opportunities in Europe.

Hill Dickinson has an award winning Health and Life Sciences team, currently acting for more than 100 independent healthcare, pharmaceutical, life-science, artificial intelligence and biotech/biomedical companies as well as over 100 NHS bodies and regulators.

Hill Dickinson’s sector knowledge combined with its relationship with public health, life sciences and regulatory bodies un the UK, ensures the Firm provides a first-class and cost-effective solution on a wide range of legal transactions and matters affecting the medical cannabis industry.

Auditors

The UHY Hacker Young Group is a network of independent accounting and consulting firms, which currently comprises over 100 partners and 540 professional staff providing a full range of services from our 23 offices across the UK. since GW Pharma in 2001. As an established brand we plan to capitalize in the timeliest manner while the market is still expanding aggressively and services are still in high demand. Currently, the market for CBD products is in extremely high demand and there are just a handful of suppliers who can manufacture the products we will be offering to our customers.

NEWS

×

Privacy Policy

Effective date: April 28, 2019

Winchester MD Limited ("us", "we", or "our") operates the https://www.winchestermd.com website (hereinafter referred to as the "Service").

This page informs you of our policies regarding the collection, use and disclosure of personal data when you use our Service and the choices you have associated with that data.

We use your data to provide and improve the Service. By using the Service, you agree to the collection and use of information in accordance with this policy. Unless otherwise defined in this Privacy Policy, the terms used in this Privacy Policy have the same meanings as in our Terms and Conditions, accessible from https://www.winchestermd.com

Definitions

Information Collection and Use

We collect several different types of information for various purposes to provide and improve our Service to you.

Types of Data Collected

Personal Data

While using our Service, we may ask you to provide us with certain personally identifiable information that can be used to contact or identify you ("Personal Data"). Personally identifiable information may include, but is not limited to:

We may use your Personal Data to contact you with newsletters, marketing or promotional materials and other information that may be of interest to you. You may opt out of receiving any, or all, of these communications from us by following the unsubscribe link or instructions provided in any email we send or by contacting us.

Usage Data

We may also collect information on how the Service is accessed and used ("Usage Data"). This Usage Data may include information such as your computer's Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Service that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.

Tracking & Cookies Data

We use cookies and similar tracking technologies to track the activity on our Service and we hold certain information.

Cookies are files with a small amount of data which may include an anonymous unique identifier. Cookies are sent to your browser from a website and stored on your device. Other tracking technologies are also used such as beacons, tags and scripts to collect and track information and to improve and analyse our Service.

You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Service.

Examples of Cookies we use:

Use of Data

Winchester MD Limited uses the collected data for various purposes:

Legal Basis for Processing Personal Data under the General Data Protection Regulation (GDPR)

If you are from the European Economic Area (EEA), Winchester MD Limited legal basis for collecting and using the personal information described in this Privacy Policy depends on the Personal Data we collect and the specific context in which we collect it.

Winchester MD Limited may process your Personal Data because:

Retention of Data

Winchester MD Limited will retain your Personal Data only for as long as is necessary for the purposes set out in this Privacy Policy. We will retain and use your Personal Data to the extent necessary to comply with our legal obligations (for example, if we are required to retain your data to comply with applicable laws), resolve disputes and enforce our legal agreements and policies.

Winchester MD Limited will also retain Usage Data for internal analysis purposes. Usage Data is generally retained for a shorter period of time, except when this data is used to strengthen the security or to improve the functionality of our Service, or we are legally obligated to retain this data for longer periods.

Transfer of Data

Your information, including Personal Data, may be transferred to — and maintained on — computers located outside of your state, province, country or other governmental jurisdiction where the data protection laws may differ from those of your jurisdiction.

If you are located outside United Kingdom and choose to provide information to us, please note that we transfer the data, including Personal Data, to United Kingdom and process it there.

Your consent to this Privacy Policy followed by your submission of such information represents your agreement to that transfer.

Winchester MD Limited will take all the steps reasonably necessary to ensure that your data is treated securely and in accordance with this Privacy Policy and no transfer of your Personal Data will take place to an organisation or a country unless there are adequate controls in place including the security of your data and other personal information.

Disclosure of Data

Disclosure for Law Enforcement

Under certain circumstances, Winchester MD Limited may be required to disclose your Personal Data if required to do so by law or in response to valid requests by public authorities (e.g. a court or a government agency).

Legal Requirements

Winchester MD Limited may disclose your Personal Data in the good faith belief that such action is necessary to:

Security of Data

The security of your data is important to us but remember that no method of transmission over the Internet or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.

Our Policy on "Do Not Track" Signals under the California Online Protection Act (CalOPPA)

We do not support Do Not Track ("DNT"). Do Not Track is a preference you can set in your web browser to inform websites that you do not want to be tracked.

You can enable or disable Do Not Track by visiting the Preferences or Settings page of your web browser.

Your Data Protection Rights under the General Data Protection Regulation (GDPR)

If you are a resident of the European Economic Area (EEA), you have certain data protection rights. Winchester MD Limited aims to take reasonable steps to allow you to correct, amend, delete or limit the use of your Personal Data.

If you wish to be informed about what Personal Data we hold about you and if you want it to be removed from our systems, please contact us.

In certain circumstances, you have the following data protection rights:

Please note that we may ask you to verify your identity before responding to such requests.

You have the right to complain to a Data Protection Authority about our collection and use of your Personal Data. For more information, please contact your local data protection authority in the European Economic Area (EEA).

Service Providers

We may employ third party companies and individuals to facilitate our Service ("Service Providers"), provide the Service on our behalf, perform Service-related services or assist us in analysing how our Service is used.

These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.

Analytics

We may use third-party Service Providers to monitor and analyse the use of our Service.

Links to Other Sites

Our Service may contain links to other sites that are not operated by us. If you click a third party link, you will be directed to that third party's site. We strongly advise you to review the Privacy Policy of every site you visit.

We have no control over and assume no responsibility for the content, privacy policies or practices of any third party sites or services.

Children's Privacy

Our Service does not address anyone under the age of 18 ("Children").

We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Child has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.

Changes to This Privacy Policy

We may update our Privacy Policy from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.

We will let you know via email and/or a prominent notice on our Service, prior to the change becoming effective and update the "effective date" at the top of this Privacy Policy.

You are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.

Contact Us

If you have any questions about this Privacy Policy, please contact us:

To Learn More, Reach out

 

Privacy Policy